These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 34566977

  • 21. C3 Glomerulopathy: Pathogenesis and Treatment.
    Ahmad SB, Bomback AS.
    Adv Chronic Kidney Dis; 2020 Mar; 27(2):104-110. PubMed ID: 32553242
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Changes in the complement system in membranoproliferative glomerulonephritis].
    Yurova VA, Bobrova LA, Kozlovskaya NL, Korotchaeva YV, Serova AG, Kozlov LV, Andina SS, Demyanova KA, Kuchieva AM, Roshchupkina SV.
    Ter Arkh; 2017 Mar; 89(6):69-77. PubMed ID: 28745692
    [Abstract] [Full Text] [Related]

  • 25. C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis.
    Xiao X, Pickering MC, Smith RJ.
    Semin Thromb Hemost; 2014 Jun; 40(4):465-71. PubMed ID: 24799308
    [Abstract] [Full Text] [Related]

  • 26. [Membranoproliferative glomerulonephritis and C3 glomerulopathy].
    Hohenstein B, Amann K, Menne J.
    Internist (Berl); 2019 May; 60(5):458-467. PubMed ID: 30859280
    [Abstract] [Full Text] [Related]

  • 27. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
    Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G, Shao D, Akber A, Fremeaux-Bacchi V, Sethi S, Nester CM, Smith RJH.
    Am J Kidney Dis; 2017 Dec; 70(6):834-843. PubMed ID: 28838767
    [Abstract] [Full Text] [Related]

  • 28. CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Zipfel PF, Wiech T, Stea ED, Skerka C.
    J Am Soc Nephrol; 2020 Feb; 31(2):241-256. PubMed ID: 31980588
    [Abstract] [Full Text] [Related]

  • 29. Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort.
    Michels MAHM, Wijnsma KL, Kurvers RAJ, Westra D, Schreuder MF, van Wijk JAE, Bouts AHM, Gracchi V, Engels FAPT, Keijzer-Veen MG, Dorresteijn EM, Volokhina EB, van den Heuvel LPWJ, van de Kar NCAJ.
    Pediatr Nephrol; 2022 Mar; 37(3):601-612. PubMed ID: 34476601
    [Abstract] [Full Text] [Related]

  • 30. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
    Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, Rubis N, Peraro F, Gaspari F, Pasini A, Rigotti A, Lerchner RM, Santoro D, Pisani A, Pasi A, Remuzzi G, EAGLE Study Group.
    Am J Kidney Dis; 2019 Aug; 74(2):224-238. PubMed ID: 30929851
    [Abstract] [Full Text] [Related]

  • 31. C3 glomerulopathy: clinicopathologic features and predictors of outcome.
    Medjeral-Thomas NR, O'Shaughnessy MM, O'Regan JA, Traynor C, Flanagan M, Wong L, Teoh CW, Awan A, Waldron M, Cairns T, O'Kelly P, Dorman AM, Pickering MC, Conlon PJ, Cook HT.
    Clin J Am Soc Nephrol; 2014 Jan; 9(1):46-53. PubMed ID: 24178974
    [Abstract] [Full Text] [Related]

  • 32. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis.
    Gupta N, Wakefield DN, Clapp WL, Garin EH.
    Nefrologia; 2017 Jan; 37(1):78-86. PubMed ID: 27595516
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. C3 glomerulopathy.
    Servais A, Noël LH, Frémeaux-Bacchi V, Lesavre P.
    Contrib Nephrol; 2013 Jan; 181():185-93. PubMed ID: 23689580
    [Abstract] [Full Text] [Related]

  • 35. Complement dysregulation in glomerulonephritis.
    Kaartinen K, Safa A, Kotha S, Ratti G, Meri S.
    Semin Immunol; 2019 Oct; 45():101331. PubMed ID: 31711769
    [Abstract] [Full Text] [Related]

  • 36. Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.
    Kersnik Levart T, Ferluga D, Vizjak A, Mraz J, Kojc N.
    Diagn Pathol; 2016 Oct 07; 11(1):94. PubMed ID: 27717365
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.